SignPath Pharma, Inc. — Form D

SignPath Pharma, Inc. of QUAKERTOWN, PA, a company, filed a Form D exempt-offering notice with the SEC on 2020-08-28. The offering totals $10.0M, of which $525K was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (29)

Showing 25 of 29 people.

NameRoleLocation
Arthur P Bollon, Ph.DDirectorSandy, UT
Robert P SegusoDirectorSandy, UT
Robert P SegusoExecutive OfficerSandy, UT
Peter P SordilloExecutive OfficerSandy, UT
Timothy P ToloukianExecutive OfficerSandy, UT
Robert SegusoDirectorSandy, UT
Robert SegusoExecutive OfficerSandy, UT
Peter SordilloExecutive OfficerSandy, UT
Arthur Ballon, Ph.DDirectorSandy, UT
Arthur Ballon, Ph.DExecutive OfficerSandy, UT
Kai LarsonDirectorSandy, UT
Kai LarsonExecutive OfficerSandy, UT
Timothy TouloukianExecutive OfficerSandy, UT
Beth P HechtDirectorSandy, UT
Robert P SagusoDirectorSandy, UT
Jack P Levine, CPADirectorSandy, UT
Kai P Larson, JDExecutive OfficerCenter Valley, PA
Lawrence D HelsonDirectorCenter Valley, PA
Lawrence D HelsonExecutive OfficerCenter Valley, PA
None P Meyers Associates, L.P.PromoterNew York, NY
N/A P Meyers Associates, L.P.PromoterNew York, NY
Arthur D BollonDirectorQuakertown, PA
Meyers D Associates, L.P.PromoterNew York, NY
Jack D LevineDirectorQuakertown, PA
Arthur P BollonDirectorQuakertown, PA

Other filings by this issuer (11)

FiledFormOfferingSold
2021-05-12D$11.0M$1.6M
2017-12-18D$5.0M$235K
2016-07-15D$5.0M$245K
2016-01-27D/A$3.0M$2.4M
2014-11-26D$5.0M$320K
2014-06-05D/A$5.0M$4.4M
2013-03-22D$5.0M$1.0M
2012-05-04D/A$3.0M$1.3M
2011-10-04D$3.0M$580K
2010-06-01D$2.7M$25K
2009-03-05D$1.0M

More